324 related articles for article (PubMed ID: 22023124)
1. Effects of opsonization of Rhodococcus equi on bacterial viability and phagocyte activation.
Dawson DR; Nydam DV; Price CT; Graham JE; Cynamon MH; Divers TJ; Felippe MJ
Am J Vet Res; 2011 Nov; 72(11):1465-75. PubMed ID: 22023124
[TBL] [Abstract][Full Text] [Related]
2. Effects of two commercially available immunostimulants on leukocyte function of foals following ex vivo exposure to Rhodococcus equi.
Ryan C; Giguère S; Fultz L; Long MT; Crawford PC
Vet Immunol Immunopathol; 2010 Dec; 138(3):198-205. PubMed ID: 20822815
[TBL] [Abstract][Full Text] [Related]
3. Use of Rhodococcus equi virulence-associated protein for immunization of foals against R equi pneumonia.
Prescott JF; Nicholson VM; Patterson MC; Zandona Meleiro MC; Caterino de Araujo A; Yager JA; Holmes MA
Am J Vet Res; 1997 Apr; 58(4):356-9. PubMed ID: 9099378
[TBL] [Abstract][Full Text] [Related]
4. Protection against naturally acquired Rhodococcus equi pneumonia in foals by administration of hyperimmune plasma.
Madigan JE; Hietala S; Muller N
J Reprod Fertil Suppl; 1991; 44():571-8. PubMed ID: 1795301
[TBL] [Abstract][Full Text] [Related]
5. Survival of foals with experimentally induced Rhodococcus equi infection given either hyperimmune plasma containing R. equi antibody or normal equine plasma.
Perkins GA; Yeager A; Erb HN; Nydam DV; Divers TJ; Bowman JL
Vet Ther; 2002; 3(3):334-46. PubMed ID: 12447842
[TBL] [Abstract][Full Text] [Related]
6. Recognition of a B-cell epitope of the VapA protein of Rhodococcus equi in newborn and experimentally infected foals.
Phumoonna T; Barton MD; Heuzenroeder MW
J Vet Med B Infect Dis Vet Public Health; 2005 Aug; 52(6):291-5. PubMed ID: 16219093
[TBL] [Abstract][Full Text] [Related]
7. PNAG-specific equine IgG
Rocha JN; Dangott LJ; Mwangi W; Alaniz RC; Bordin AI; Cywes-Bentley C; Lawhon SD; Pillai SD; Bray JM; Pier GB; Cohen ND
Vaccine; 2019 Feb; 37(9):1142-1150. PubMed ID: 30691984
[TBL] [Abstract][Full Text] [Related]
8. Hematologic and immunophenotypic factors associated with development of Rhodococcus equi pneumonia of foals at equine breeding farms with endemic infection.
Chaffin MK; Cohen ND; Martens RJ; Edwards RF; Nevill M; Smith R
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):33-48. PubMed ID: 15182994
[TBL] [Abstract][Full Text] [Related]
9. Rhodococcus (Corynebacterium) equi: bactericidal capacity of neutrophils from neonatal and adult horses.
Martens JG; Martens RJ; Renshaw HW
Am J Vet Res; 1988 Mar; 49(3):295-9. PubMed ID: 3358541
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of a peptide-ELISA based upon N-terminal B-cell epitope of the VapA protein for diagnosis of Rhodococcus equi pneumonia in foals.
Phumoonna T; Muscatello G; Chicken C; Gilkerson JR; Browning GF; Barton MD; Heuzenroeder MW
J Vet Med B Infect Dis Vet Public Health; 2006 Apr; 53(3):126-32. PubMed ID: 16629724
[TBL] [Abstract][Full Text] [Related]
11. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine.
Cauchard J; Sevin C; Ballet JJ; Taouji S
Vet Microbiol; 2004 Nov; 104(1-2):73-81. PubMed ID: 15530741
[TBL] [Abstract][Full Text] [Related]
12. Opsonization but not pretreatment of equine macrophages with hyperimmune plasma nonspecifically enhances phagocytosis and intracellular killing of Rhodococcus equi.
Harvey AB; Bordin AI; Rocha JN; Bray JM; Cohen ND
J Vet Intern Med; 2021 Jan; 35(1):590-596. PubMed ID: 33326149
[TBL] [Abstract][Full Text] [Related]
13. Cytokine expression by neutrophils of adult horses stimulated with virulent and avirulent Rhodococcus equi in vitro.
Nerren JR; Payne S; Halbert ND; Martens RJ; Cohen ND
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):135-43. PubMed ID: 19019457
[TBL] [Abstract][Full Text] [Related]
14. Development of ELISA test for determination of the level of antibodies against Rhodococcus equi in equine serum and colostrum.
Witkowski L; Kaba J; Rzewuska M; Nowicki M; Szaluś-Jordanow O; Kita J
Vet Immunol Immunopathol; 2012 Oct; 149(3-4):280-5. PubMed ID: 22883938
[TBL] [Abstract][Full Text] [Related]
15. Rhodococcus equi pneumonia in the foal--part 1: pathogenesis and epidemiology.
Muscatello G
Vet J; 2012 Apr; 192(1):20-6. PubMed ID: 22015138
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia.
Hooper-McGrevy KE; Giguere S; Wilkie BN; Prescott JF
Am J Vet Res; 2001 Aug; 62(8):1307-13. PubMed ID: 11497456
[TBL] [Abstract][Full Text] [Related]
17. Validation and evaluation of VapA-specific IgG and IgG subclass enzyme-linked immunosorbent assays (ELISAs) to identify foals with Rhodococcus equi pneumonia.
Sanz MG; Oliveira AF; Loynachan A; Page A; Svansson V; Giguère S; Horohov DW
Equine Vet J; 2016 Jan; 48(1):103-8. PubMed ID: 25257622
[TBL] [Abstract][Full Text] [Related]
18. The influence of age and Rhodococcus equi infection on CD1 expression by equine antigen presenting cells.
Pargass IS; Wills TB; Davis WC; Wardrop KJ; Alperin DC; Hines SA
Vet Immunol Immunopathol; 2009 Aug; 130(3-4):197-209. PubMed ID: 19285733
[TBL] [Abstract][Full Text] [Related]
19. Assessment in mice of vapA-DNA vaccination against Rhodococcus equi infection.
Haghighi HR; Prescott JF
Vet Immunol Immunopathol; 2005 Apr; 104(3-4):215-25. PubMed ID: 15734542
[TBL] [Abstract][Full Text] [Related]
20. A potential role for indoleamine 2,3-dioxygenase (IDO) in Rhodococcus equi infection.
Heller MC; Drew CP; Jackson KA; Griffey S; Watson JL
Vet Immunol Immunopathol; 2010 Dec; 138(3):174-82. PubMed ID: 20739070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
